| IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus (NCT04400994) | The University of Hong Kong | 2020-06-20 |
| A Study of PRN1008 in Patients With Pemphigus (NCT03762265) | Principia Biopharma, a Sanofi Company | 2019-01-08 |
| FARD (RaDiCo Cohort) (RaDiCo-FARD) (NCT05954416) | Institut National de la Santé Et de la Recherche Médicale, France | 2018-03-07 |
| A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus) (NCT03075904) | Alexion Pharmaceuticals, Inc. | 2017-07-18 |
| Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population (NCT05284929) | Sechenov University | 2017-05-17 |
| Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris (NCT02613910) | GlaxoSmithKline | 2015-12-23 |
| Identification of Vulnerability Factors in the Course of Pemphigus Patients (NCT02237313) | University Hospital, Rouen | 2015-04-20 |
| Wound Dressings for Pemphigus and Pemphigoid (NCT02365675) | Fundación Nacional para la Enseñanza y la Investigación de la Dermatología A.C. | 2015-01-01 |
| Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid (NCT01559155) | Centre Hospitalier Universitaire de Nīmes | 2013-11-05 |
| Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus (NCT01974518) | Uprety Shraddha | 2013-11-01 |
| Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab (NCT01299857) | University Hospital, Rouen | 2011-06-01 |
| Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus (NCT01313923) | University of California, Irvine | 2011-02-01 |
| Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus (NCT00656656) | University of Luebeck | 2008-01-01 |
| Use of Infliximab for the Treatment of Pemphigus Vulgaris (NCT00283712) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Effect of Anti CD20 in Pemphigus Desease (NCT00213512) | University Hospital, Rouen | 2003-06-01 |
| Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders (NCT00278642) | Richard Burt, MD | 2002-09-01 |
| European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus (NCT00127764) | University Medical Center Groningen | 2001-01-01 |
| Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus (NCT00010413) | Johns Hopkins University | 1999-04-01 |